Source: Pubmed
"Use of convalescent plasma in COVID-19 patients with immunosuppression."
Senefeld JW, Klassen SA, Ford SK, Senese KA, Wiggins CC, Bostrom BC, et al. (incl. Hartman WR) Transfusion Vol 61 Iss 8 Pages 2503-2511 2021 Aug PMID: 34036587 PMCID: PMC8242637
"The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis."
Klassen SA, Senefeld JW, Johnson PW, Carter RE, Wiggins CC, Shoham S, et al. (incl. Hartman WR) Mayo Clinic Proceedings Vol 96 Iss 5 Pages 1262-1275 2021 May PMID: 33958057 PMCID: PMC7888247
"Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest."
Hartman WR, Hess AS, Connor JP, Translational Medicine Communications Vol 5 Iss 1 Pages 17 2020 PMID: 33072871 PMCID: PMC7549340
"Unusual Cardiac Presentation of COVID-19 and Use of Convalescent Plasma."
Hartman WR, Hess AS, Connor JP, Case Reports In Cardiology Vol 2020 Pages 8863195 2020 PMID: 33062340 PMCID: PMC7537691
"Hospitalized COVID-19 Patients Treated With Convalescent Plasma in a Mid-size City in The Mid West."
Hartman WR, Hess AS, Connor JP, Research Square 2020 Aug 6 [Preprint] PMID: 32793897 PMCID: PMC7418745
"Persistent viral RNA shedding after COVID-19 symptom resolution in older convalescent plasma donors."
Hartman WR, Hess AS, Connor JP, Transfusion Vol 60 Iss 10 Pages 2189-2191 2020 Oct PMID: 32533556 PMCID: PMC7323103
More Info
William Hartman, MD, PhD
Assistant Professor
Department of Anesthesiology
University of Wisconsin
(608) 263-6807